




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Cardiac Surgery and Heart Failure</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=c5ff91a9-f0f4-4291-84b8-6604ce7c4778</link>
        <description>Clinical Topic Feed: Cardiac Surgery and Heart Failure</description>
        <language>en</language>

        

                <item>
                    <title>Eagle&#226;€™s Eye View: Imaging Identifies HCM Patients at High-Risk of Adverse Outcomes </title>
<link>/Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment.</description>
                    <pubdate>1779288780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Science at ESC Heart Failure Congress 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026</link>                    <description>Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA...</description>
                    <pubdate>1778607960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>SURVIV: mViV vs. rMVR For Mitral Bioprosthetic Valve Dysfunction</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-surviv-acc-2026</link>                    <description>Among patients with a failed mitral bioprosthetic valve, transcatheter mitral valve-in-valve (mVIV) treatment was associated with a lower rate of death or disabling stroke at one year compared with standard repeat mitral valve replacement surgery (rMVR), according to results from the SURVIV study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans.</description>
                    <pubdate>1774818000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC State-of-the-Art Review Highlights Growing Need For dLVAD-Related Emergency Response Resources</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/03/12/18/40/JACC-State-of-the-Art</link>                    <description>With the population of stage D heart failure (HF) patients supported with durable left ventricular assist devices (dLVAD) rapidly expanding, a State-of-the-Art Review published in JACC provides a comprehensive overview of support and management of dLVAD-related emergencies, with an intent to provide a rapid-response guide for clinicians who encounter emergencies in patients with dLVADs.</description>
                    <pubdate>1773343260000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Hot Topics in Congenital and Pediatric Cardiology in the Year 2025</title>
<link>/Latest-in-Cardiology/Articles/2026/02/19/11/58/Hot-Topics-in-Congenital-and-Pediatric-Cardiology-in-the-Year-2025</link>                    <description>The pace of innovation in congenital and pediatric cardiology continued to accelerate in 2025, shaped by practice&#226;€‘defining guidelines, multicenter investigations, and growing bench&#226;€‘to&#226;€‘bedside translation.</description>
                    <pubdate>1771850460000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Noninvasive Predictors of LA Compliance Post TMVT</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/02/09/18/56/Noninvasive-Predictors</link>                    <description>In patients with severe mitral regurgitation (MR), low left atrial (LA) reservoir strain (LASr) and prior atrial fibrillation (AFib) intervention or LA appendage (LAA) ligation may predict low invasive LA compliance and limited V-wave reduction after transcatheter mitral valve therapy (TMVT)...</description>
                    <pubdate>1770667920000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Can Exercise SBP Relative to Level of Fitness Be Associated with Increased CV Events?</title>
<link>/Latest-in-Cardiology/Articles/2026/01/28/14/24/eagles-eye-view-28jan2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at exercise systolic blood pressure (SBP) during stress testing related to cardiovascular (CV) events.</description>
                    <pubdate>1769610360000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>REUP For DCD Feasible Regardless of Donor Age, Ischemic Time</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/01/22/18/26/REUP-For-DCD</link>                    <description>Rapid recovery with extended ultraoxygenated preservation (REUP) for donation after circulatory death (DCD) was found to be feasible regardless of donor age and ischemic time, according to a study published Jan. 26 in JAMA.</description>
                    <pubdate>1769520060000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Focus on Heart Failure | Clinical Considerations to Unlock the Potential of LVAD Therapy</title>
<link>/Latest-in-Cardiology/Articles/2025/11/01/01/Focus-on-Heart-Failure</link>                    <description>For select patients with advanced heart failure (AHF), durable left ventricular assist device (LVAD) therapy can be a life-sustaining option that improves quality of life. Since its introduction a few decades ago, the technology and associated clinical outcomes have evolved in a transformational manner.</description>
                    <pubdate>1761999180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>For the FITs | Fighting Against the Tide: Graduate Training in AHFTC</title>
<link>/Latest-in-Cardiology/Articles/2025/11/01/01/For-the-FITs</link>                    <description>Over the past four decades, the field of advanced heart failure/transplant cardiology (AHFTC) has undergone remarkable transformation in both clinical practice and fellowship training.</description>
                    <pubdate>1761999120000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>